Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Subaru1, before I head out, Mr. Pidduck clearly used the
View:
Post by subaru1i on Oct 03, 2023 2:18pm

Subaru1, before I head out, Mr. Pidduck clearly used the

term "partner" within the context of a business discussion be it the CC or press release.   Would not then a "partner" facilitate some kind of written agreement between Medipharm Labs and their "traditonal global pharmaceutical partner".   Tilray is now a customer but not a partner.   There's a big difference within the scope of business language.   This is why I humoursly brought up a "pre-nup" agreement.   Perhaps this will help you formulate your own conclusions.   When those comments are made publicly be it a press release or conference call by the CEO of the company, someone is held legally liable if those statements are not true.   For example, I work for Chysler and I am a plant manager.   If there is a serious health and safety issue, I am legally responsible as plant manager and if a serious accident occurs causing the loss of life, I can be legally accountable for negligent manslaughter.  So when the CEO says they have that partner as I referenced earlier, he too is held legally liable up to and including criminal charge for making a false statement.  We are not here about buddies referring to each other as partners.   Partner in the business sense does have a legal definition.  Perhaps looking it up will help put your mind at ease a bit more.   I know it's not easy at times, I understand how "worry" can creep into your mind and play havoc with clarity and logic.  Do not succumb to that type of skull f'k.
Comment by okgonow on Oct 03, 2023 3:27pm
partners come and partners go ! until the cat is out of the bag we had,have or will have a partner, how much of a partnership is anyones guess. lets just keep it real for now but im allways ready to party like its 1999 afer all the big news gets revealed. until then I will be cautiously optemistic and not blindly go into the light
Comment by subaru1i on Oct 03, 2023 5:19pm
Fair enough but the CEO also mentioned their inability to reveal their "traditional global pharmaceutical partner" FOR COMPETITIVE REASONS. Those last three words indicates very clearly commercial development that is not yet available to be released publicly.    You can go back and check out that fact for yourself by listening towards the end of one of the conference ...more  
Comment by subaru1 on Oct 04, 2023 12:37pm
Subaru1i for the trial, i have ounce received a graph with only six trial in progress and only one was to be in stage 3 in 2023 with the results coming out in the 1 qrt of 2024. I was expecting to receive this graph on a qrt basis but i received one time and that's it. So how these trials are progressing we have no idea. For now with LAbs is what you see is what you get $0,075.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities